Related Experiment Video
Updated: Feb 19, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Availability and Patterns of Intravesical BCG Instillations
S Awomir Poletajew1, Aleksandra Majek2, Piotr Magusiak2
1Department of Urology, Medical University of Warsaw, Warsaw, Poland.. slawomir.poletajew@wum.edu.pl.
Purpose:
Intravesical BCG instillations improve recurrence free survival in patients with non-muscle-invasive bladder cancer (NMIBC).
Methods:
This is a national survey study, covering 223 urological centres, aimed at reliable identification of BCG availability and implemented treatment patterns.
Results:
Response rate was 93.7%. BCG was used in 56.5% of urological departments. Another 22.7% referred patients to other hospitals for instillations, while 20.8% did not recommend BCG at all. The most common indications for BCG instillations were as follows: T1 tumours (88.5%), carcinoma in situ (83.6%) and high grade tumours (73.8%). Maintenance therapy was routinely abandoned in 16.4% of centres or was scheduled for <1 year, 1 year, 3 years and 1-3 years in 6.6%, 19.7%, 21.3% and 31.2% of centres, respectively. Continuation of BCGdespite treatment failure in carcinoma in situ cases was considered in 21.3% of departments.
Conclusion:
Our findings indicate that BCG is underused, while patterns of maintenance and follow-up are suboptimal.
Related Concept Videos
01:22Imaging Studies VI: Voiding Cystourethrography and Cystography
01:22Imaging Studies V: Intravenous Urography and Retrograde Pyelography
01:21Intrauterine Drug Delivery Systems